United Kingdom News
Most Popular United Kingdom Story
UK health officials in cancer vaccine fight
When British health officials weighed the benefits of the two cervical cancer vaccines, they concluded that Cervarix from GlaxoSmithKline provided the best value for the money. And that decision... Read more...
Latest Headlines
- September 17, 2009
- May 14, 2009
- January 21, 2009
- June 19, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
